Ethan Lovell is a seasoned leader in healthcare and corporate strategy, currently serving as the Senior Director of Investor Relations at Avidity Biosciences, Inc. Since 2023, they have also held the position of Head of Investor Relations at Theravance Biopharma US, Inc. With previous experience at Agenus as Chief External Affairs & Communications Officer and a foundational role at Janus Henderson Investors, where they co-managed a $10B healthcare equity portfolio, Ethan combines expertise in healthcare investments with a strong background in strategic communications. They hold an MBA in Finance from Tulane University and a Master of Arts in Media and Public Communication from the University of Denver, where they pursued research into health insurance perceptions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices